Raül Agut

Raül Agut

Auto-generated profile, based on publicly available information

Raül Agut

Departament de Química Inorgànica i Orgànica, Universitat Jaume I, E-12071 Castellón, Spain

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CMCelia Martín-Beltrán
Celia Martín-Beltrán
RERaquel Gil Edo
Raquel Gil Edo
GHGermán Hernández-Ribelles
Germán Hernández-Ribelles
RARaül Agut
Raül Agut
PMPilar Marí-Mezquita
Pilar Marí-Mezquita
EFEva Falomir
Eva Falomir
Twenty-one styryl and phenethyl aryl ureas have been synthetized and biologically evaluated as multitarget inhibitors of Vascular endothelial growth factor receptor-2 VEGFR-2 and programmed death-ligand-1 (PD-L1) proteins in order to overcome resistance phenomena offered by cancer. The antiproliferative activity of these molecules on several tumor cell lines (HT-29, MCF-7, HeLa and A549), on the endothelial cell line human microvascular endothelial cells (HMEC)-1 and on the non-tumor cell line human embryonic kidney cells (HEK)-293 has been determined. Some derivatives were evaluated for their antiangiogenic properties such as their ability to inhibit microvessel formation using HMEC-1 or their effect on VEGFR-2 in both cancer and endothelial cell lines. In addition, the immunomodulator action of a number of selected compounds was also studied on PD-L1 and c-Myc proteins. Compounds 16 and 23 (Z) and (E)-styryl p-bromophenyl urea, respectively, showed better results than sorafenib in down-regulation of VEGFR-2 and also improved the effect of the anti-PD-L1 compound BMS-8 on both targets, PD-L1 and c-Myc proteins.

4 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RARaül Agut
Raül Agut
EFEva Falomir
Eva Falomir
JMJuan Murga
Juan Murga
CMCelia Martín-Beltrán
Celia Martín-Beltrán
RERaquel Gil Edo
Raquel Gil Edo
JMJ. Alberto Marco
J. Alberto Marco
Natural product combretastatin A-4 (CA-4) and its nitrogenated analogue 3′-aminocombretastatin A-4 (AmCA-4) have shown promising antitumor activities. In this study, a range of CA-4 and AmCA-4 derivatives containing amino acid pendants have been synthesized in order to compare their biological actions with those of their parent compounds. Thus, inhibition of cell proliferation on tumor cell lines HT-29, MCF-7 and A-549, as well as on the nontumor cell line HEK-273; in vitro tubulin polymerization; mitotic cell arrest; action on the microtubule cell network and inhibition of VEGF, hTERT, and c-Myc genes have been evaluated. Some AmCA-4 derivatives bearing L-amino acids exhibited inhibition of cell proliferation at low nanomolar levels exceeding the values shown by AmCA-4. Furthermore, while CA-4 and AmCA-4 derivatives do not show significant effects on the in vitro tubulin polymerization and cell cycle arrest, some selected CA-4 and AmCA-4 derivatives are able to cause total depolymerization of the microtubule network on A-549 cells. The best results were obtained in the inhibition of gene expression, particularly on the VEGF gene, in which some AmCA-4 derivatives greatly exceeded the inhibition values achieved by the parent compound.

14 July 2017
Verified
Thesis
Open access
RMRaül Agut Montoliu
Raül Agut Montoliu
La presente tesis doctoral trata la síntesis y evaluación biológica de derivados de combretastatina y aminocombretastatina. Concretamente, se han sintetizado 62 derivados, los cuales incorporan aminoácidos de las series L y D y cadenas alifáticas de entre 4 y 12 átomos de carbono de longitud. La evaluación biológica de estos derivados consistió en el estudio de su actividad antiproliferativa frente a las líneas celulares HT-29, MCF-7, A-549 y HEK-293; el estudio de las propiedades antimitóticas mediante ensayos del efecto de los derivados sobre el proceso de polimerización in vitro de la tubulina, el efecto sobre el ciclo celular y el efecto sobre la red de microtúbulos celulares; y el estudio de su efecto frente a la inhibición de los genes hTERT y c-Myc, relacionados con la telomerasa y también del gen VEGF relacionado con el proceso de angiogénesis.This tesis deals with the synthesis and biological evaluation of combretastatin and aminocombretastatin derivatives. Specifically, 62 derivatives have been synthesized wich incorporate amino acids from L and D series and aliphatic chains between 4 and 12 carbon atoms in lenght. The biological evaluation of this derivatives consisted in the study of their antiproliferative activity againts HT-29, MCF-7, A-549 and HEK-293 cell lines; the study of the antimitotic properties was performed by assays of the effect of the derivatives on the in vitro polymerization process of tubulin, the effect on the cell cycle and the effect on the cellular microtubule network. It was also performed the study of this effect againts hTERT and c-Myc genes expression, related to telomerase and also to the VEGF gene, related to the angiogenesis process